TrialBritish journal of clinical pharmacology2015

An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.

Sigurd D Süssmuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.